Cargando…
Thiazolidinedione-Induced Fluid Retention: Recent Insights into the Molecular Mechanisms
Peroxisome proliferator-activated receptor-γ (PPARγ) agonists such as rosiglitazone and pioglitazone are used to improve insulin sensitivity in patients with diabetes mellitus. However, thiazolidinediones induce fluid retention, edema, and sometimes precipitate or exacerbate heart failure in a subse...
Autores principales: | Bełtowski, Jerzy, Rachańczyk, Jolanta, Włodarczyk, Mirosław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614122/ https://www.ncbi.nlm.nih.gov/pubmed/23577024 http://dx.doi.org/10.1155/2013/628628 |
Ejemplares similares
-
Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
por: Yang, Tianxin, et al.
Publicado: (2008) -
Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
por: Horita, Shoko, et al.
Publicado: (2015) -
Recent Pharmacological Developments on Rhodanines and 2,4-Thiazolidinediones
por: Bhatti, Ravinder Singh, et al.
Publicado: (2013) -
Molecular Mechanism of Thiazolidinedione-Mediated Inhibitory Effects on Osteoclastogenesis
por: Zhao, Dongfeng, et al.
Publicado: (2014) -
Chemotherapy and Chemoprevention by Thiazolidinediones
por: Fröhlich, Eleonore, et al.
Publicado: (2015)